Planet Biotechnology produced the first plant-made antibody, or “plantibody”, ever tested in a clinical trial. We are focused on discovering, developing and commercializing new antibody-based therapeutic and preventative products through cultivation of genetically modified green plants to meet significant underserved medical needs. Scientists at Planet Biotechnology identify and develop promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. We routinely adapt our antibody and receptor-antibody products for rapid production in non-food, non-feed green plants grown in greenhouses. This same approach has been used by others to produce three anti-Ebola virus antibodies that are undergoing clinical trials in Africa.
View Top Employees from Planet Biotechnology, Inc.Website | http://www.planetbiotechnology.com |
Revenue | $7 million |
Employees | 5 (5 on RocketReach) |
Founded | 1998 |
Address | 20980 Corsair Blvd, Hayward, California 94545, US |
Phone | (510) 887-1461 |
Technologies | |
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Medical, Health Care, Therapeutics |
Web Rank | 16 Million |
Keywords | Planet Biotechnologies Inc |
Competitors | Precision Antibody, ProMab Biotechnologies, Inc., Proteos, Sympros, Inc, exonbio |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Planet Biotechnology, Inc. employee's phone or email?
The Planet Biotechnology, Inc. annual revenue was $7 million in 2024.
Keith Wycoff is the Vice President of Research of Planet Biotechnology, Inc..
5 people are employed at Planet Biotechnology, Inc..
Planet Biotechnology, Inc. is based in Hayward, California.
The NAICS codes for Planet Biotechnology, Inc. are [54171, 54, 541714, 5417, 541].
The SIC codes for Planet Biotechnology, Inc. are [873, 87].